1. Serum non‐coding RNAs for diagnosis and stage of liver fibrosis
   Chao Liu et al, 2022, Journal of Clinical Laboratory Analysis CrossRef
2. Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis
   Kritika Karri et al, 2023, RNA CrossRef
3. Hepatocyte‐derived exosomes deliver the lncRNA CYTOR to hepatic stellate cells and promote liver fibrosis
   Wenqiang Xu et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
4. The Role of Long non-coding RNA MEG3 in Fibrosis Diseases
   Wenlong Wu et al, 2023, null CrossRef
5. MEG3 shuttled by exosomes released from human bone marrow mesenchymal stem cells promotes TP53 stability to regulate MCM5 transcription in keloid fibroblasts
   Feibin Zhu et al, 2024, The Journal of Gene Medicine CrossRef
6. Silencing lncRNA KCNQ1OT1 reduced hepatic ischemia reperfusion injury-induced pyroptosis by regulating miR-142a-3p/HMGB1 axis
   Canxin Liang et al, 2023, Molecular and Cellular Biochemistry CrossRef
7. Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non‐alcoholic fatty liver disease
   Shreyoshi Guha et al, 2023, Cell Biochemistry and Function CrossRef
8. Human liver stem cell-derived extracellular vesicles modulate long non-coding RNA expression profile in an in vivo model of non-alcoholic steatohepatitis
   Giulia Chiabotto et al, 2023, Exploration of Digestive Diseases CrossRef